CANNRA urges federal action to provide a regulatory framework for hemp-derived cannabinoid products. These products currently lack federal manufacturing, testing, and labeling requirements, and they pose consumer safety and public health risks. In the absence of federal regulation, state government agencies have borne the brunt of the efforts to effectively regulate cannabinoid hemp products.

This letter outlines the three primary loopholes being used to justify the sale of intoxicating hemp-derived products: the “0.3% loophole,” the “THCA loophole,” and the “derivatives loophole.” The letter discusses several key considerations raised by state cannabis and hemp regulators as the Farm Bill language is revised and cannabinoid hemp product regulation is debated.

As regulatory discussions on this topic continue, state cannabis and hemp regulators are vital to have at the table as a group of government officials with direct regulatory experience related to cannabinoid products.

More at 

https://www.cann-ra.org/news-events/sx2s63c2fudq9n0zmk4ekviku9747f

Sean Hocking

Source link

You May Also Like

Key Things To Know About Hemp And Marijuana Drinks

Hemp and marijuana beverages represent about $4 billion in sales and are…

New Study Reveals Potential Benefits of Cannabis for COVID-19 Patients | High Times

Years now after the height of the pandemic, a new study shows…

Innovation, Education, and High-Quality CBD: Inside ZAR Wellness’s Mission – Medical Marijuana Program Connection

… promotion of this product. CBD products have been increasingly popular ……

Marijuana MSO Columbia Care raises $25 million in private placement – Medical Marijuana Program Connection

New York-based marijuana multistate operator Columbia Care entered … Original Author Link…